Gastrointestinal complications are relatively frequent in Ehlers-Danlos syndrome (EDS). Intestinal dysmotility is significantly more frequent in EDS patients than in general population and it has a very difficult investigational approach, requiring a high clinical suspicion for diagnosis. Therapeutic approach may be challenging in the context of limited options and disabling nature of the disease. EDS is considered a multisystem disease, as connective tissue is present throughout the body, the digestive tract can be affected as well. Previous studies have associated EDS with a spectrum of gastrointestinal complications such as chronic constipation, hiatus hernia, Crohn's disease, fecal incontinence, rectal evacuatory dysfunction, functional gastrointestinal disorder, gastroesophageal reflux, recurrent gastritis, delayed gastric emptying and recurrent abdominal pain. In this case series, the authors report six cases of global gut dysmotility in Ehlers-Danlos syndrome. We try to highlight that EDS can lead to significant gut failure that is not only difficult to diagnose but is challenging to treat. All the patient's required at least one form of nutritional support either by tube feeding or intravenous nutrition. Some of the patient's required surgical intervention to treat the significant dysmotility. The table below shows our patients characteristics, diagnostic and feeding methods and the surgical intervention if needed. All the reported patients were females diagnosed clinically with EDS hypermobility type (type 3), mean age was 24 years, mean BMI was 23 kg /m2. Five of them diagnosed with POTS (cases 1, 2, 3, 4, 5), only one patient had Mast cell activation syndrome (case 1).Three patients were diagnosed with SIBO (cases 3, 4, 6), five patients required parenteral nutrition (cases 1, 2, 4, 5, 6). Five patients needed tube feeds at some point (cases 1, 2, 4, 5, 6). (See table1). Sever gut dysmotility among patients with Ehlers-Danlos syndrome is not uncommon and possibly underdiagnosed. It must always be taken into account when treating EDS patients with persistent gastro-intestinal symptoms, especially in the presence of autonomic dysfunction features (including POTS) and failure to maintain weight.Table: Table. POTS, postural orthostatic tachycardia syndrome; SIBO, small intestinal bacterial overgrowth; MCAS, mast cell activation syndrome; SBFT, small bowel follow through
Read full abstract